ROCKVILLE, Md., Jan. 25 /PRNewswire-FirstCall/ -- Novavax, Inc. a clinical-stage vaccine company, announced today that the company will be presenting at the upcoming Phacilitate Vaccine Forum Washington 2010. The Conference will take place January 25-27, 2010 at the Grand Hyatt, Washington, D.C. Mr. John Trizzino, Senior Vice President of International and Government Alliances will be participating in a Focus Session: Fast Tracking the development of - and path to licensure for - a novel manufacturing platform by utilizing it in pandemic influenza efforts on January 26, 2010 at 4:15pm.
About Vaccine Forum Washington 2010
The conference program features a highly stimulating mixture of business, regulatory, investment and public policy topics, with the speaker panel featuring high level representatives of vaccine developers themselves, as well as key government agencies, non-government agencies and analysts. For more information visit: www.phacilitate.co.uk
Novavax, Inc.
